{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T17:29:03Z","timestamp":1748971743013},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1097\/ftd.0000000000000225","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T21:57:26Z","timestamp":1433282246000},"page":"776-782","source":"Crossref","is-referenced-by-count":9,"title":["The Influence of Plasma Albumin Concentration on the Analysis Methodology of Free Valproic Acid by Ultrafiltration and Its Application to Therapeutic Drug Monitoring"],"prefix":"10.1097","volume":"37","author":[{"given":"Zhi-qing","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-chong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Hui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-jun","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-le","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210129","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.drudis.2011.12.018","article-title":". Compilation of 222 drugs plasma protein binding data and guidance for study designs.","volume":"17","author":"Zhang","year":"2012","journal-title":"Drug Discov Today"},{"key":"R2-12-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cca.2006.08.026","article-title":"Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management.","volume":"377","author":"Dasgupta","year":"2007","journal-title":"Clin Chim Acta"},{"key":"R3-12-20210129","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.seizure.2007.12.007","article-title":"Value of therapeutic drug level monitoring and unbound (free) levels.","volume":"17","author":"Chan","year":"2008","journal-title":"Seizure"},{"key":"R4-12-20210129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jchromb.2006.07.062","article-title":". Simple reversed-phase liquid chromatographic assay for simultaneous quantification of free mycophenolic acid and its glucuronide metabolite in human plasma.","volume":"846","author":"Yau","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R5-12-20210129","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jchromb.2008.11.010","article-title":". High performance liquid chromatographic determination of plasma free and total tazobactam and piperacillin.","volume":"877","author":"Di Giovamberardino","year":"2009","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R6-12-20210129","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.ijantimicag.2009.08.005","article-title":". Correlation between free and total vancomycin serum concentrations in patients treated for Gram positive infections.","volume":"34","author":"Berthoin","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"R7-12-20210129","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jchromb.2006.05.042","article-title":"Investigation of high-throughput ultrafiltration for the determination of an unbound compound in human plasma using liquid chromatography and tandem mass spectrometry with electrospray ionization.","volume":"843","author":"Zhang","year":"2006","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R8-12-20210129","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/01.ftd.0000173373.12569.c7","article-title":"Effect of ultrafiltrate volume on determination of free phenytoin concentration.","volume":"27","author":"McMillin","year":"2005","journal-title":"Ther Drug Monit"},{"key":"R9-12-20210129","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ejps.2012.11.006","article-title":". Effect of volume ratio of ultrafiltrate to sample solution on the analysis of free drug and measurement of free carbamazepine in clinical drug monitoring.","volume":"48","author":"Dong","year":"2013","journal-title":"Eur J Pharm Sci"},{"key":"R10-12-20210129","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1345\/aph.1P308","article-title":"High unbound fraction of valproic acid in a hypoalbuminemic critically ill patient on renal replacement therapy.","volume":"45","author":"Maat","year":"2011","journal-title":"Ann Pharmacother"},{"key":"R11-12-20210129","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0887-8994(03)00310-2","article-title":". Hypoalbuminemia with valproic acid administration.","volume":"29","author":"Rugino","year":"2003","journal-title":"Pediatr Neurol"},{"key":"R12-12-20210129","first-page":"531","article-title":"Lafont T, et al..","volume":"71","author":"Gandia","year":"2013","journal-title":"Should therapeutic drug monitoring of the unbound fraction of imatinib and its main active metabolite N-desmethyl-imatinib be developed Cancer Chemother Pharmacol"},{"key":"R13-12-20210129","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jchromb.2006.11.013","article-title":"Determination of valproic acid in human serum and pharmaceutical preparations by headspace liquid-phase microextraction gas chromatography-flame ionization detection without prior derivatization.","volume":"850","author":"Shahdousti","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R14-12-20210129","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00007691-198206000-00009","article-title":"Monitoring free valproic acid in epilepsy patients medicated with coanticonvulsants.","volume":"4","author":"Haidukewych","year":"1982","journal-title":"Ther Drug Monit"},{"key":"R15-12-20210129","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/00007691-199212000-00013","article-title":". Determination of free valproic acid: evaluation of the Centrifree system and comparison between high-performance liquid chromatography and enzyme immunoassay.","volume":"14","author":"Liu","year":"1992","journal-title":"Ther Drug Monit"},{"key":"R16-12-20210129","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jchromb.2012.08.037","article-title":". Determination of free and total valproic acid in human plasma by capillary electrophoresis with contactless conductivity detection.","volume":"907","author":"Pham","year":"2012","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"R17-12-20210129","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1093\/chromsci\/bmt167","article-title":". A new derivatization method to enhance sensitivity for the determination of low levels of valproic acid in human plasma.","volume":"52","author":"Zhang","year":"2014","journal-title":"J Chromatogr Sci"},{"key":"R18-12-20210129","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.jchromb.2011.05.012","article-title":". Developing a robust ultrafiltration-LC-MSMS method for quantitative analysis of unbound vadimezan (ASA404) in human plasma.","volume":"879","author":"Li","year":"2011","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0000000000000225","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:29:43Z","timestamp":1620952183000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201512000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000225","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}